The right commercialization model for a digital health product is a key component of success in this rapidly growing space. However, whether you choose a pharma partnership or another popular distribution channel, success is likely to depend on physician awareness of your digital health product and their willingness to prescribe or recommend it. Germany’s Digital Healthcare Act (DVG) and the Digital Health Applications Ordinance (DiGAV) have the potential to play a key role in not only providing a path to reimbursement, but also for increasing provider awareness and trust in digital health solutions.
What do you need to know to navigate the DiGa framework? Join us in this interactive masterclass led by Flying Health, who will walk us through:
- General overview and current landscape: what DiGa is and what it’s not, why it is an opportunity for digital health companies in the EU market, digital health tools approved so far, average price and current prescription & adoption rates. - How to apply, requirements and keys to succeed: what products are eligible to apply, evidence needed, pricing, data security, UX, interoperability, reporting significant changes in the product, etc.
- Once you have your DiGa approved, what else do you need to do to ensure a high number of prescriptions and patient adoption?